Talkspace (TALK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
9 Mar, 2026Executive summary
Entered into a definitive merger agreement for acquisition by Universal Health Services, Inc. via a wholly owned subsidiary, with the target becoming an indirect wholly owned subsidiary post-merger.
Each outstanding share will be converted into the right to receive $5.25 in cash, and all securities will be delisted from NASDAQ following the merger.
The merger is subject to customary closing conditions, including shareholder approval, regulatory clearances, and absence of legal restraints.
The agreement includes a $32,394,000 termination fee payable under certain circumstances, such as acceptance of a superior proposal.
Forward-looking statements highlight risks related to regulatory approvals, competing offers, integration, and potential litigation.
Voting matters and shareholder proposals
The board unanimously approved the merger agreement and recommends shareholders vote in favor.
Voting agreements were executed with major shareholders representing approximately 14% of outstanding shares, committing to vote in favor of the merger and against alternative proposals.
Shareholders will be asked to approve the merger and related actions at a special meeting.
Board of directors and corporate governance
The board determined the merger is in the best interests of shareholders and received a fairness opinion from its financial advisor.
Post-merger, the directors and officers of the surviving corporation will be those of the merger subsidiary.
The agreement includes provisions for indemnification and continued D&O insurance for six years post-closing.
Latest events from Talkspace
- Definitive agreement for acquisition by UHS to create a national behavioral health continuum.TALK
Proxy Filing9 Mar 2026 - UHS to acquire Talkspace for $835M, expanding virtual behavioral health services nationwide.TALK
Proxy Filing9 Mar 2026 - 2025 revenue up 22% to $229M, adjusted EBITDA up 127%, with strong 2026 growth outlook.TALK
Q4 202519 Feb 2026 - Director elections, auditor ratification, and executive pay were key agenda items.TALK
AGM 20243 Feb 2026 - Q2 revenue up 29%, net loss narrowed, and share repurchase authority expanded to $32M.TALK
Q2 20242 Feb 2026 - Q3 revenue up 23% to $47.4M, net income positive, Payor segment drives growth.TALK
Q3 202418 Jan 2026 - AI-driven solutions and payer partnerships drive growth and position the platform for leadership.TALK
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Profitable, AI-driven behavioral health platform targets 200M covered lives and 25% annual growth.TALK
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Expanding in-network mental health access with AI innovation and targeted market growth.TALK
Barclays 27th Annual Global Healthcare Conference26 Dec 2025